Ginkgo Bioworks Holdings

Healthcare · Biotechnology

12.40$ -17.2% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Ginkgo Bioworks Holdings (DNA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 990 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet DNA
Line item	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	–	–	–	675	643	587	2,151	2,071	2,071	1,994	1,871	2,539	2,417	2,292	2,026	1,665	1,582	1,625	1,481	1,377	1,293	1,231	1,189	1,120	1,033	990
Current Assets	495	–	–	427	362	284	1,811	1,723	1,723	1,599	1,462	1,450	1,327	1,223	1,142	1,002	903	783	662	603	565	523	506	472	410	333
Cash	-495	–	–	381	308	236	1,739	1,550	1,550	1,377	1,303	1,316	1,206	1,106	1,049	944	844	730	616	562	312	204	111	167	144	85
Cash & Short-Term Investments	495	–	–	381	308	236	1,739	1,550	1,550	1,377	1,303	1,316	1,206	1,106	1,049	949	844	730	616	562	517	474	462	423	373	302
Receivables	–	–	–	22	31	28	51	150	132	175	116	82	85	68	63	18	25	19	24	22	27	23	21	24	20	13
Inventory	–	–	–	9.3	3.4	2.7	3.5	3.4	3.4	8.1	5.9	4.4	2.5	0.4	0.1	0.0	0.0	–	–	–	–	–	–	–	–	–
Property, Plant & Equipment	–	–	–	–	142	146	143	146	149	176	188	716	314	686	543	–	–	–	617	598	581	562	545	529	–	–
Goodwill	–	–	–	1.9	1.9	1.9	17	21	21	31	29	60	59	59	58	49	48	0.0	0.0	0.0	–	–	–	–	–	–
Intangible Assets	–	–	–	3.3	3.2	3.0	23	22	22	39	48	111	109	105	100	83	77	91	80	73	69	66	62	57	49	44
Total Liabilities	–	–	–	205	248	231	533	504	504	427	431	803	810	788	774	568	594	792	683	661	646	618	629	611	590	570
Current Liabilities	–	–	–	73	99	81	90	135	135	135	125	173	192	163	168	164	169	166	114	107	116	97	115	96	80	73
Short-Term Debt	–	–	–	0.5	–	0.0	0.0	0.7	0.0	0.0	0.0	29	0.0	0.0	0.0	20	–	–	0.0	29	0.0	0.0	0.0	23	–	–
Accounts Payable	–	–	–	14	14	2.8	7.1	8.2	8.2	19	11	10	22	14	11	9.3	27	23	16	14	11	11	11	11	16	9.6
Shareholders' Equity	502	–	–	461	388	349	1,552	1,505	1,505	1,535	1,435	1,736	1,608	1,504	1,253	1,097	987	833	798	716	647	613	560	509	443	420
Retained Earnings	–	–	–	-468	-541	-595	-697	-2,298	-2,298	-3,557	-4,226	-4,398	-4,603	-4,776	-5,079	-5,291	-5,456	-5,674	-5,730	-5,838	-5,929	-5,989	-6,070	-6,150	-6,233	-6,280
Shares Outstanding	30	30	32	32	32	32	33	38	1,607	1,621	1,631	46	48	49	49	50	50	51	52	52	54	55	56	55	60	62

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings